Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation
Clinical trial NCT06102213 · TERMINATED
Trial details
- NCT number
- NCT06102213
- Sponsor
- Prolacta Bioscience
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2024-08-12
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.